Publications

Detailed Information

Cinnamaldehyde enhances cytotoxic effect of cisplatin by ROS-induced autophagy in cisplatin-resistant ovarian cancer cells. : cisplatin에 저항성을 지닌 난소암세포에서 cinnamaldehyde와 cisplatin의 조합에 의해 발생한 ROS로부터 유도된 자가포식 기전 연구

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors

정재영

Advisor
송용상
Major
농업생명과학대학 농생명공학부
Issue Date
2017-02
Publisher
서울대학교 대학원
Keywords
Ovarian cancerChemoresistanceAutophagyCinnamaldehydeReactive oxygen species
Description
학위논문 (석사)-- 서울대학교 대학원 : 농생명공학부, 2017. 2. 송용상.
Abstract
Ovarian cancer is the most lethal gynecologic cancer. A major obstacle to the current therapy for ovarian cancer is the platinum-resistance. Cisplatin (CDDP) is representatively platinum-based drug and has anti-cancer effect by triggering reactive oxygen species (ROS) in various cancer cells. Cinnamaldehyde (CA), extracted from the stem bark of Cinnamomum cassia, has been shown to possess anticancer effects in various cancers and to induce apoptotic cell death by ROS generation. According to previous studies, induction of ROS by cellular stressors promotes autophagic cell death as well as apoptosis in many cancers. So, we tested whether CA and CDDP boost ROS-mediated apoptosis and autophagy and also have synergistic effect in ovarian cancer cells. We chose two types of ovarian cancer cell lines (A2780/s sensitive to CDDP and A2780/cis resistant to CDDP). Low dose (1 µM) of CDDP appeared cytotoxicity and induced ROS-mediated apoptosis and autophagy in A2780/s. But high dose (10 µM) of CDDP was not affected in A2780/cis. In this condition, co-treatment of CA remarkably increased synergistic growth-inhibitory effect and induced ROS-mediated apoptosis and autophagy in A2780/cis. Thus, excessive ROS by combination of CA and CDDP might be proposed to a way to overcome the chemoresistance in ovarian cancer.
Language
English
URI
https://hdl.handle.net/10371/125990
Files in This Item:
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share